MC Home
    • Latest News
    • Drug News
    • Conference Highlights
    • Quizzes
    • Ask the PharmD
    • Special Reports
    • Alzheimer’s & Dementia
    • Arthritis & Rheumatic Diseases
    • Asthma & Allergy
    • Behavioral & Mental Health
    • Cancer & Blood Disorders
    • Cardiovascular Disorders
    • COVID
    • Diabetes
    • Endocrine Disorders
    • Gastrointestinal Disorders
    • Infectious Diseases
    • Kidney Disease
    • Low Back Pain
    • Medication Management
    • Migraine
    • Neurological Disorders
    • Obesity & Weight Management
    • Ophthalmic Disorders
    • Pain Management
    • Preventive & Routine Care
    • Skin Disorders
    • Sleep Disorders
    • Substance Use Disorder
    More Topics
    • Burnout & Wellbeing
    • Clinician Profiles
    • Business & Policy
    • Podcasts
    • Calculators
    • Coding & Reimbursement
    • Conversation Starters
    • Guidelines
    • Drug Search
    • Check Drug Interactions

Latest News

Liver Disease

New Algorithm Discerns Cancer Risk in Advanced Chronic Liver Disease

Racheal Ede
News
4 Min Read

A novel risk-stratification model could support personalized HCC surveillance.

Liver Disease

New Algorithm Discerns Cancer Risk in Advanced Chronic Liver Disease

Racheal Ede
News
4 Min Read

A novel risk-stratification model could support personalized HCC surveillance.

Skin Disorders

Latest JAK Inhibitor for Alopecia Areata Shows Continued Scalp Hair Regrowth

Katy Henriksen
News
3 Min Read

Results of 68-week study of deuruxolitinib.

Skin Disorders

Latest JAK Inhibitor for Alopecia Areata Shows Continued Scalp Hair Regrowth

Katy Henriksen
News
3 Min Read

Results of 68-week study of deuruxolitinib.

Cardiovascular Disorders

Can Beta-Blockers Increase Depression in Patients with CVD?

Suchandrima Bhowmik
News

Results of a REDUCE-AMI sub-study.

Cardiovascular Disorders

Can Beta-Blockers Increase Depression in Patients with CVD?

Suchandrima Bhowmik
News

Results of a REDUCE-AMI sub-study.

Cardiovascular Disorders

Novel Oral Drug Takes Next Step in Race to Lower Lipoprotein(a)

Patrice Wendling
News
5 Min Read

Muvalaplin is the first oral drug among a host of injectable agents to target this common but underdiagnosed cardiovascular risk factor. AHA 2024 conference coverage.

Cardiovascular Disorders

Novel Oral Drug Takes Next Step in Race to Lower Lipoprotein(a)

Patrice Wendling
News
5 Min Read

Muvalaplin is the first oral drug among a host of injectable agents to target this common but underdiagnosed cardiovascular risk factor. AHA 2024 conference coverage.

Dr. Oz
Business & Policy

Trump Chooses Dr. Oz to Lead Medicare, Medicaid

Marcia Frellick
News
3 Min Read

The surgeon and TV personality has supported universal healthcare and has clashed with healthcare leaders on several fronts.

Dr. Oz
Business & Policy

Trump Chooses Dr. Oz to Lead Medicare, Medicaid

Marcia Frellick
News
3 Min Read

The surgeon and TV personality has supported universal healthcare and has clashed with healthcare leaders on several fronts.

Blood thinners
Cardiovascular Disorders

Blood Thinners Fail to Prevent Cognitive Decline, Stroke in AF

Patrice Wendling
News
5 Min Read

The BRAIN-AF results dash hopes for anticoagulation in younger, low-risk patients. AHA 2024 Conference Coverage.

Blood thinners
Cardiovascular Disorders

Blood Thinners Fail to Prevent Cognitive Decline, Stroke in AF

Patrice Wendling
News
5 Min Read

The BRAIN-AF results dash hopes for anticoagulation in younger, low-risk patients. AHA 2024 Conference Coverage.

Arthritis & Rheumatic Diseases

Natural Killer Cell Therapy: An “Off-the-Shelf” Option for SLE?

Kathleen Doheny
News
3 Min Read

Could an allogenic approach replace CAR T cell therapy? ACR Convergence 2024 coverage.

Arthritis & Rheumatic Diseases

Natural Killer Cell Therapy: An “Off-the-Shelf” Option for SLE?

Kathleen Doheny
News
3 Min Read

Could an allogenic approach replace CAR T cell therapy? ACR Convergence 2024 coverage.

Cardiovascular Disorders

Tirzepatide Cuts Heart Failure Events in People with Obesity

Patrice Wendling
News
5 Min Read

SUMMIT trial widens pathway for GLP-1 agonists, experts say. AHA 2024 meeting coverage.

Cardiovascular Disorders

Tirzepatide Cuts Heart Failure Events in People with Obesity

Patrice Wendling
News
5 Min Read

SUMMIT trial widens pathway for GLP-1 agonists, experts say. AHA 2024 meeting coverage.

Endocrine Disorders

How Opioids Disrupt Endocrine Health

Racheal Ede
News
5 Min Read

New scientific statement fills gaps in understanding opioid-induced endocrinopathies. What to know, and what to ask patients.

Endocrine Disorders

How Opioids Disrupt Endocrine Health

Racheal Ede
News
5 Min Read

New scientific statement fills gaps in understanding opioid-induced endocrinopathies. What to know, and what to ask patients.

Child in hospital
Cancer & Blood Disorders

U.S. News Releases Pediatric Cancer Rankings

Youssef Rddad
News
3 Min Read

U.S. News & World Report recently released its annual rankings of pediatric hospitals, including the top children’s hospitals that treat cancer.

Child in hospital
Cancer & Blood Disorders

U.S. News Releases Pediatric Cancer Rankings

Youssef Rddad
News
3 Min Read

U.S. News & World Report recently released its annual rankings of pediatric hospitals, including the top children’s hospitals that treat cancer.

Obesity & Weight Management

Drug Labeling Gaps for Patients with Obesity Could Lead to Poor Outcomes

Leah Lawrence
News
5 Min Read

What does the FDA intend to do? Plus, how to avoid prolonged drug-drug interactions. An ObesityWeek 2024 highlight.

Obesity & Weight Management

Drug Labeling Gaps for Patients with Obesity Could Lead to Poor Outcomes

Leah Lawrence
News
5 Min Read

What does the FDA intend to do? Plus, how to avoid prolonged drug-drug interactions. An ObesityWeek 2024 highlight.

Coding & Reimbursement

2025 Medicare Fee Schedule Targets Telehealth, Primary Care

Torrey Kim
News
5 Min Read

Unless Congress intervenes, the 2025 Final Rule introduces a 2.8% cut in the conversion rate and reduces accepted telehealth codes and waivers.

Coding & Reimbursement

2025 Medicare Fee Schedule Targets Telehealth, Primary Care

Torrey Kim
News
5 Min Read

Unless Congress intervenes, the 2025 Final Rule introduces a 2.8% cut in the conversion rate and reduces accepted telehealth codes and waivers.

Trending

Business & Policy

“Discouraging” Data on High-Paying Specialties

Marcia Frellick
News
3 Min Read
Female doctor holding US currency
Business & Policy

Get Nearly 20% of Your EHR Time Back

Leslie Kane, MA
5 Min Read
Medical staff on computer
Business & Policy

Communities of Practice: How to Find Your People

Michael D. McGee, MD
Podcast
Nephrology

Nephrologists “Can No Longer Ignore Obesity”

Alexis Pellek
News
4 Min Read

News you can put into practice...

Newsletters

Follow Us!

  • Share via facebook
  • Share via twitter
  • Share via linkedin
  • About Us
  • Contact Us
  • Editorial Board
  • Editorial Policy
  • Advertise With Us
  • Sitemap
  • Our Other Sites
  • Advertising Policy
  • Do Not Sell My Info
  • Privacy Policy
  • Terms of Use
© 2024 HealthCentral LLC. All rights reserved.